Cancer Research UK logo.
SearchDonate
  • Search

A trial of epacadostat for women who have a raised level of CA125 after treatment for ovarian, primary peritoneal or fallopian tube cancer

Overview

Cancer types:

Ovarian cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at a drug called epacadostat for women with ovarian cancer who had no signs of cancer after chemotherapy. But who then had a raised level of a marker called CA125 in their blood a few months later. The trial was for women who had:

These cancers are all treated in the same way. So, when we use the term ovarian cancer in this summary, we are referring to all 3.

Recruitment start: 7 March 2013

Recruitment end: 27 March 2014

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Rebecca Kristeleit

Supported by

Incyte Corporation

Last reviewed: 9 January 2019

CRUK internal database number: 10816

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.